We are live on ! Find out more
SCM

Salem Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 8.82%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
-8.82%
3 Year Est. Return
+32.26%
5 Year Est. Return
+45.09%
10 Year Est. Return
AUM
$210M
AUM Growth
-$4.47M
Cap. Flow
-$4.17M
Cap. Flow %
-1.98%
Top 10 Hldgs %
37.48%
Holding
72
New
1
Increased
9
Reduced
37
Closed
1

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$608K
2
PHG icon
Philips
PHG
+$508K
3
CVS icon
CVS Health
CVS
+$366K
4
OXY icon
Occidental Petroleum
OXY
+$290K
5
KO icon
Coca-Cola
KO
+$249K

Sector Composition

Rank Sector Weight
1 Healthcare 25.53%
2 Energy 15.23%
3 Technology 14.89%
4 Industrials 13.49%
5 Consumer Staples 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
1
CVS Health
CVS
$124B
$10.8M 5.16%
112,504
-4,150
-4% -$366K
JNJ icon
2
Johnson & Johnson
JNJ
$663B
$8.37M 3.98%
80,050
-1,350
-2% -$142K
WY icon
3
Weyerhaeuser
WY
$16.6B
$7.98M 3.8%
222,232
-4,300
-2% -$148K
HON icon
4
Honeywell
HON
$66.4B
$7.68M 3.65%
85,508
-1,558
-2% -$134K
DD
5
DELISTED
Du Pont De Nemours E I
DD
$7.59M 3.61%
108,068
-2,949
-3% -$197K
NVS icon
6
Novartis
NVS
$304B
$7.57M 3.6%
91,138
-2,232
-2% -$185K
IP icon
7
International Paper
IP
$19.7B
$7.47M 3.56%
147,280
-2,957
-2% -$145K
MSFT icon
8
Microsoft
MSFT
$3.71T
$7.12M 3.39%
153,171
-3,800
-2% -$178K
UL icon
9
Unilever
UL
$138B
$7.11M 3.39%
156,165
-2,525
-2% -$116K
MRK icon
10
Merck
MRK
$371B
$7.01M 3.34%
129,458
+471
+0.4% +$26.2K
PFE icon
11
Pfizer
PFE
$162B
$6.96M 3.31%
235,465
-2,740
-1% -$78.6K
PG icon
12
Procter & Gamble
PG
$340B
$6.7M 3.19%
73,518
-2,700
-4% -$238K
GE icon
13
GE Aerospace
GE
$350B
$6.41M 3.05%
52,965
-960
-2% -$118K
INTC icon
14
Intel
INTC
$506B
$6.38M 3.04%
175,955
-4,040
-2% -$141K
PCAR icon
15
PACCAR
PCAR
$65.6B
$6.34M 3.02%
139,781
-2,700
-2% -$117K
CSCO icon
16
Cisco
CSCO
$431B
$5.74M 2.73%
206,500
-5,750
-3% -$148K
DD icon
17
DuPont de Nemours
DD
$17.8B
$5.63M 2.68%
48,758
-1,086
-2% -$132K
DVN icon
18
Devon Energy
DVN
$52.9B
$5.22M 2.49%
85,294
-2,950
-3% -$179K
EMC
19
DELISTED
EMC CORPORATION
EMC
$5.17M 2.46%
173,710
-3,150
-2% -$91.7K
GSK icon
20
GSK
GSK
$100B
$4.92M 2.34%
92,016
-4,400
-5% -$246K
MRO
21
DELISTED
Marathon Oil Corporation
MRO
$4.88M 2.32%
172,625
-3,150
-2% -$100K
SLB icon
22
SLB Ltd
SLB
$85.3B
$4.84M 2.3%
56,663
-100
-0.2% -$9.2K
RTX icon
23
RTX Corp
RTX
$271B
$4.24M 2.02%
58,612
+80
+0.1% +$5.45K
VOD icon
24
Vodafone
VOD
$39.1B
$4.21M 2%
123,063
-72
-0.1% -$2.43K
ABB
25
DELISTED
ABB Ltd
ABB
$4.01M 1.91%
189,575
-5,350
-3% -$116K

Similar funds

Salem Capital Management's Q4 2014 Portfolio in Review

As of Q4 2014, Salem Capital Management held 72 positions worth $210M, down 2.1% from $215M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 2.8%. Salem Capital Management opened 1 new position and exited 1, leaving the 72-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Energy and Technology.

  • Salem Capital Management's largest Q4 2014 buy was California Resources Corporation: 1,689 shares worth $93K.
  • Salem Capital Management added most to PLUM CREEK TIMBER CO (REIT) in Q4 2014, an estimated $534K increase.
  • Salem Capital Management's biggest Q4 2014 reduction was AbbVie, cutting an estimated $608K.
  • Salem Capital Management fully exited Coca-Cola in Q4 2014, selling an estimated $249K.
  • Salem Capital Management's ten largest holdings make up 37% of its $210M portfolio in Q4 2014.
  • Salem Capital Management opened 1 new position and closed 1 in Q4 2014.
  • Salem Capital Management's portfolio value fell 2.1% quarter-over-quarter to $210M.

Based on Salem Capital Management's 13F filing for Q4 2014, filed 15 Jan 2015.